Evidence map›Paper›PMID 41347236›Full record

ReviewFrontiers in microbiology2025

Molecular epidemiology of methicillin-resistant

Ahmed Briki, Nada Alkhatib, Bisola Aloba, Subham Verma, Rania Nassar, Dean Everett, Ralf Ehricht, Stefan Monecke, Abiola Senok

Erratum issuedAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Methicillin-ResistantInternational journal of molecular sciences · 2026
    Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Ahmed Briki *College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Nada Alkhatib *College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Bisola AlobaCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Subham VermaCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Rania NassarCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Dean EverettDepartment of Public Health and Epidemiology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates.
Ralf EhrichtLeibniz Institute of Photonic Technology (IPHT), Leibniz Center for Photonics in Infection Research (LPI), Jena, Germany.
Stefan MoneckeLeibniz Institute of Photonic Technology (IPHT), Leibniz Center for Photonics in Infection Research (LPI), Jena, Germany.
Abiola SenokCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methicillin-resistant Aim: This scoping review evaluates MRSA data in GCC countries-United Arab Emirates (UAE), Saudi Arabia, Kuwait, Qatar, Oman, and Bahrain-focusing on prevalence trends, molecular characteristics, and gaps in the literature. Methods: A systematic search of the PubMed (National Library of Medicine [NLM], National Institutes of Health [NIH]) database was conducted to identify literature published between January 2010 and July 2025, using predefined keywords on MRSA epidemiology. Eligible studies were reviewed for MRSA prevalence, clonal diversity, antimicrobial resistance patterns, and virulence profiles. Results: Of 864 records screened, 97 met the inclusion criteria and were subjected to detailed review. Most studies originated from Saudi Arabia (58%), followed by Kuwait (26%), UAE (7%), Oman (3%), Qatar (2%), Bahrain (2%), and two involving adjacent countries (2%). Data indicate a predominance of community-associated MRSA (CA-MRSA) across both healthcare and community settings. Several studies reported novel or rare MRSA strains across various GCC countries. Moreover, there is clear evidence of widespread resistance to multiple classes of antibiotics, highlighting the growing concern of multidrug-resistant MRSA. Increasing prevalence of strains with virulence/resistance genes such as Conclusion: MRSA in the GCC shows dynamic and evolving patterns. Continuous surveillance through coordinated regional efforts is essential. A One Health approach, combined with strengthened antimicrobial stewardship, mandatory hospital screenings, and wastewater monitoring, could improve MRSA detection, tracking, and control across the region.

Indexed as

antimicrobial resistanceepidemiologyGCCmethicillin-resistantMiddle EastprevalenceS. aureus

Identifiers

PMID41347236
PMCPMC12673209

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.